MedicinesFAQ

BMS-214662

BMS-214662 Uses, Dosage, Side Effects, Food Interaction and all others data.

BMS-214662 has been used in trials studying the treatment of Childhood Myelodysplastic Syndromes, Refractory Anemia With Excess Blasts, Recurrent Adult Acute Myeloid Leukemia, Relapsing Chronic Myelogenous Leukemia, and Adult Acute Promyelocytic Leukemia (M3), among others.

Trade Name	BMS-214662
Generic	BMS-214662
Type
Formula	C₂₅H₂₃N₅O₂S₂
Weight	Average: 489.612 Monoisotopic: 489.129316385
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	September 19, 2023 at 7:00 am

Innovators Monograph

You find simplified version here BMS-214662

Content Sources

https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=448545
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=347828513
https://www.chemspider.com/Chemical-Structure.395310.html
http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50092365
https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL351706
https://zinc.docking.org/substances/ZINC000003925649
https://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/BMV

*** Taking medicines without doctor's advice can cause long-term problems.

Download Bissoy app from Play Store to get doctor's consultation over video call